Skip to main content
Top

Drugs

Issue 10/2012

Content (8 Articles)

Targeting the Glutamatergic System to Treat Major Depressive Disorder

  • Leading Article

Daniel C. Mathews, Ioline D. Henter, Carlos A. Zarate Jr

Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation

  • Therapy In Practice

Lu Huber, Nils Lachmann, Michael Dürr, Mareen Matz, Lutz Liefeldt, Hans-H. Neumayer, Constanze Schönemann, Klemens Budde

Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues

  • Review Article

Florent Aptel, Christophe Chiquet, Jean-Paul Romanet

Heart Failure in Hypertension

  • Review Article

Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, Javed Butler

Catumaxomab

  • Adis Drug Profile

James E. Frampton

Mannitol Dry Powder for Inhalation

  • Adis Drug Profile

Celeste B. Burness, Gillian M. Keating

Vandetanib

  • Adis Drug Profile

James E. Frampton

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images